Physiol Rev 56(4):778826 Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets
Our study identifies a previously unrecognized site of DM1 molecular pathogenesis and highlights the potential of urinary EVs as biomarkers of renal and metabolic disturbance in these individuals
Clinical studies have used series of several to a dozen or so administrations, for example two or three times a week for four to six weeks
Exosome injection and animal grouping To evaluate whether exosomes from patients with HACE impair learning, memory, and cognitive function, we administered continuous exosome injections to the bilateral dentate DG of mice
Its superior bioavailability makes these benefits more pronounced compared to non-liposomal forms